23 May 2024
23 May 2024
The trial met the primary endpoint with high and low doses of rilzabrutinib leading to a numerical decrease in LOAC events.
Data shows the industry is turning towards decentralization to study the effects of drugs in older populations, but how can Decentralized Clinical Trials (DCTs) be implemented in a suitable, age-appropriate way?
The PressureSafe device reduced the incidence of pressure injuries by 50% by detecting these pressure injuries to the skin and underlying tissue early.
Topline results from the trial are expected to be reported in the third quarter of 2024.
The trial will enrol 140 subjects to assess efficacy of TNT with or without AN0025.
Eight patients undergoing haemodialysis were enrolled into the first in human trial, which demonstrated the safety and efficacy of H-Guard.
Approximately 250 patients with chronic plaque psoriasis will be enrolled across five trial arms.
Clinical Trials Arena spoke to 89bio’s chief medical officer Hank Mansbach, discussing potential strengths that the asset could have over its competitors.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
